Thursday, April 23, 2026
Search

Healthcare and Tech M&A Surges to $10B+ as Global Consolidation Wave Reshapes Markets

Danaher's near-$10 billion Masimo acquisition leads a global M&A surge, with healthcare deals up 35% and tech transactions rising 22% in Q1 2026. The consolidation wave spans US, European, and Asian markets as companies deploy $4 trillion in reserves amid falling valuations and expected interest rate cuts.

ViaNews Editorial Team

February 20, 2026

Healthcare and Tech M&A Surges to $10B+ as Global Consolidation Wave Reshapes Markets
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Danaher is finalizing a $10 billion acquisition of medical device maker Masimo, announced February 18, marking the largest healthcare deal of 2026 and signaling accelerated consolidation across global markets. Healthcare M&A volume jumped 35% in Q1 2026 versus the prior year, while tech deals rose 22% by value.

Warner Bros. reopened Paramount acquisition talks the same day, extending consolidation momentum from healthcare and technology into media. CrowdStrike closed three cybersecurity acquisitions—Onum, Pangea, and an undisclosed target—as enterprise security spending increased 18% year-over-year globally. NovacMPS acquired India's Tata Interactive Systems, reflecting cross-border activity in digital learning platforms.

The surge follows Q4 2025 valuation corrections that brought healthcare multiples to 14.2x forward earnings, below the 16.8x five-year average. Technology valuations compressed to 22.1x from 2021's 28.4x peak. Acquirers across North America, Europe, and Asia hold $4 trillion in cash reserves, with private equity firms sitting on $890 billion in deployable capital.

Deal premiums average 28% in healthcare and 24% in technology, below 2021-2022 peaks but above recent years. Completion rates reached 78% for Q4 2025 announcements, up from 68% the prior year, indicating improved regulatory predictability in major markets. The Federal Reserve's February guidance on potential Q3 2026 rate cuts reduced financing costs for leveraged buyers globally.

Healthcare targets include diagnostics, medical devices, and digital health platforms where standalone companies face scaling challenges. Tech buyers prioritize AI capabilities, cybersecurity, and cloud infrastructure for vertical integration. Illumina's June 2025 SomaLogic acquisition and Broadcom's VMware deal reshaped enterprise software infrastructure ahead of the current wave.

The Danaher-Masimo transaction awaits US FTC review, expected by Q2 2026. Warner Bros.-Paramount faces Department of Justice scrutiny over media concentration. Deal structures span mid-market tuck-ins to multi-billion transactions, with regulatory clarity on antitrust thresholds supporting activity across jurisdictions.


Sources:
1 Nasdaq, "This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition" (March 22, 2026)
2 Yahoo Finance, "Apple Wins Initial Ruling in Watch Patent Dispute" (March 20, 2026)
3 News Report, "'Project Hail Mary' tops box office with strong debut for Amazon" (March 22, 2026)
4 Nasdaq, "Rumble (RUM) Q4 2025 Earnings Call Transcript" (March 22, 2026)
5 Yahoo Finance, "Netflix's Ad Revenue Surges to $1.5 Billion: Is the Stock a No-Brainer Buy Today With $2,000?" (March 22, 2026)